Lab-Grown Meat Finally Tastes Good. The Price Problem Remains.
Lab-grown chicken is now indistinguishable from real chicken in blind tests. But at $17 per breast, the price problem remains unsolved.
The Taste Barrier Is Broken
Upside Foods' latest cultivated chicken, available in select San Francisco and Singapore restaurants, is indistinguishable from conventional chicken in blind taste tests. Testers correctly identified the lab-grown sample only 48% of the time — statistically equivalent to random guessing. The texture, flavor, and mouthfeel have reached parity.
This is a genuine milestone. Early cultivated meat products (2023-2024) had a detectable "off" texture — slightly mushy, lacking the fibrous structure of real muscle tissue. Upside solved this with scaffolding technology that guides cell growth along aligned fibers, mimicking natural muscle development.
The Price Problem
A cultivated chicken breast currently costs approximately $17 to produce — down from $300,000 in 2013, but still 5-7x the price of conventional chicken. Upside, Good Meat, and Mosa Meat all project cost parity by 2030, but those projections depend on massive bioreactor scaling that hasn't been demonstrated yet.
The fundamental challenge is biological: mammalian cells grow slowly and expensively compared to plant-based alternatives. Growing a kilogram of cultivated beef requires enormous amounts of growth media — the nutrient broth that cells feed on — which currently costs more than the meat itself.
The Regulatory Landscape
The U.S. approved cultivated chicken for sale in 2023. The EU is still deliberating. China approved it in 2025. The patchwork regulatory landscape means cultivated meat companies must navigate different approval processes in each market, adding years and millions to their go-to-market timeline.